Market Overview

Aurinia Pharmaceuticals to Release Second Quarter 2018 Financial Results on August 9, 2018


Conference Call and webcast to follow

Aurinia Pharmaceuticals Inc., (NASDAQ:AUPH, TSX:AUP) today announced
that it will release its second quarter 2018 financial results on
Thursday, August 9, 2018, after the market closes. Aurinia's management
will host a conference call to discuss the company's second quarter 2018
financial results and provide a general business update.

The conference call and webcast is scheduled for August 9, 2018 at
4:30pm EDT. In order to participate in the conference call, please dial
+1-877-407-9170 (Toll-free U.S. & Canada). An audio webcast can be
accessed under "News/Events" through the "Investors" section of the
Aurinia corporate website at
A replay of the webcast will be available on Aurinia's website.

About Aurinia

Aurinia is a clinical stage biopharmaceutical company focused on
developing and commercializing therapies to treat targeted patient
populations that are suffering from serious diseases with a high unmet
medical need. The company is currently developing voclosporin, an
investigational drug, for the treatment of LN, FSGS and DES. The company
is headquartered in Victoria, BC and focuses its development efforts
globally. For further information, see our website at

We seek safe harbor.

View Comments and Join the Discussion!